Wednesday 18 September 2024 Simultaneous sessions.

This article, published in Transfusion Medicine, discusses the use of red cell transfusion in sickle cell disease (SCD). The author emphasizes that transfusion is a crucial treatment for SCD, as it helps prevent and manage severe complications such as stroke, acute chest syndrome, and severe pain episodes. However, there is a higher risk of transfusion reactions in SCD patients, especially in the acute setting. Recurrent transfusion reactions can make it challenging to safely administer transfusions, which limits the availability of this life-saving intervention. The article highlights the importance of understanding these risks and using blood judiciously to ensure its availability for SCD patients. [Extracted from the article]

Copyright of Transfusion Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)